zoledronic acid has been researched along with Experimental Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Asch, AS; Kumar, G; Lightfoot, S; Madka, V; Mohammed, A; Pathuri, G; Rao, CV; Steele, VE; Zhang, Y | 1 |
| Cai, XJ; Cao, JW; Fei, WD; Ni, JJ; Tao, K; Wang, Z; Xu, H; Xu, YY; Yang, GY | 1 |
| Chantry, AD; Down, JM; Evans, H; Green, AC; Lath, D; Lawson, MA; Paton-Hough, J; Snowden, JA; Tazzyman, S | 1 |
| Ge, K; Han, Y; Jin, Y; Liang, XJ; Liu, D; Liu, H; Sun, W; Yang, X; Zhang, H; Zhang, J; Zhou, G | 1 |
| Hattori, Y; Kawano, K; Sakaida, C; Yamashita, J; Yonemochi, E | 1 |
| Huang, L; Kumta, SM; Lau, CP; Li, G; Tsui, SK; Wong, KC | 1 |
| Allen, JS; Cui, G; Esser, AK; Lanza, GM; Pan, D; Ross, MH; Schmieder, AH; Su, X; Weilbaecher, KN; Wickline, SA; Williams, T; Xiang, J; Yang, X; Zhang, H | 1 |
| Au, KM; Caster, JM; Huang, L; Kim, YS; Min, Y; Satterlee, A; Tian, X; Wang, AZ; Zhang, L; Zhang, T | 1 |
| Chen, R; Guan, Z; Jin, L; Su, X; Ye, J; Zhang, L | 1 |
| Chang, JW; Chou, WC; Huang, JS; Li, YY; Liaw, CC; Wang, CH; Wang, HM; Yeh, KY | 1 |
| Ahn, GO; Brown, JM | 1 |
11 other study(ies) available for zoledronic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model.
Topics: Administration, Oral; Alendronate; Animals; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Male; Metformin; Neoplasms, Experimental; Rats; Rats, Inbred F344; Zoledronic Acid | 2020 |
Liposome-Encapsulated Zoledronate Favors Tumor Vascular Normalization and Enhances Anticancer Efficacy of Cisplatin.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cisplatin; Endothelial Cells; Female; Humans; Liposomes; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Oligopeptides; Polyethylene Glycols; Zoledronic Acid | 2020 |
Preventing and Repairing Myeloma Bone Disease by Combining Conventional Antiresorptive Treatment With a Bone Anabolic Agent in Murine Models.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Neoplasms, Experimental; Osteolysis; Transforming Growth Factor beta; Xenograft Model Antitumor Assays; Zoledronic Acid | 2019 |
Bone-Targeted Nanoplatform Combining Zoledronate and Photothermal Therapy To Treat Breast Cancer Bone Metastasis.
Topics: 3T3-L1 Cells; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Proliferation; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Optical Imaging; Particle Size; Phototherapy; Porosity; Surface Properties; Tumor Cells, Cultured; Tumor Microenvironment; Zoledronic Acid | 2019 |
Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Diphosphonates; Female; Folic Acid; Humans; Imidazoles; KB Cells; Liposomes; Macrophages; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neovascularization, Pathologic; Tumor Cells, Cultured; Zoledronic Acid | 2015 |
A mouse model of luciferase-transfected stromal cells of giant cell tumor of bone.
Topics: Animals; Benzamides; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Female; Giant Cell Tumor of Bone; Heterografts; Humans; Imidazoles; Luciferases; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Stromal Cells; Transduction, Genetic; Xenograft Model Antitumor Assays; Zoledronic Acid | 2015 |
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.
Topics: Amino Acid Transport Systems, Neutral; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Diffusion; Diphosphonates; Imidazoles; Integrin alphaVbeta3; Male; Molecular Targeted Therapy; Nanocapsules; Neoplasms, Experimental; Prodrugs; Rabbits; Treatment Outcome; Zoledronic Acid | 2016 |
Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic.
Topics: Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Calcium; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Diphosphonates; Folic Acid; Humans; Hydrogen-Ion Concentration; Imidazoles; Metals; Nanocapsules; Nanocomposites; Neoplasms, Experimental; Organic Chemicals; Treatment Outcome; Zoledronic Acid | 2016 |
Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Cytokine-Induced Killer Cells; Cytotoxicity, Immunologic; Dendritic Cells; Diphosphonates; Humans; Imidazoles; Immunophenotyping; Immunotherapy, Adoptive; Lymphocyte Activation; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; NK Cell Lectin-Like Receptor Subfamily K; Zoledronic Acid | 2010 |
Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Disease Progression; Flow Cytometry; Imidazoles; Lung Neoplasms; Mice; Mice, Inbred BALB C; Microscopy, Phase-Contrast; Neoplasms, Experimental; Survival Rate; Treatment Outcome; Zoledronic Acid | 2008 |
Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Bone Marrow Transplantation; CD11b Antigen; Diphosphonates; Endothelial Cells; Imidazoles; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myeloid Cells; Neoplasms, Experimental; Neovascularization, Pathologic; Protease Inhibitors; Signal Transduction; Stem Cells; Subcutaneous Tissue; Time Factors; Zoledronic Acid | 2008 |